Affinity Investment Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,215
| Closed | -$787K | – | 212 |
|
|
2023
Q1 | $787K | Sell |
7,215
-38
| -0.5% | -$4.15K | 0.42% | 91 |
|
|
2022
Q4 | $825K | Buy |
7,253
+75
| +1% | +$8.54K | 0.38% | 94 |
|
|
2022
Q3 | $444K | Hold |
7,178
| – | – | 0.23% | 141 |
|
|
2022
Q2 | $573K | Sell |
7,178
-278
| -4% | -$22.2K | 0.28% | 122 |
|
|
2022
Q1 | $784K | Sell |
7,456
-1,779
| -19% | -$187K | 0.32% | 115 |
|
|
2021
Q4 | $995K | Sell |
9,235
-1,183
| -11% | -$127K | 0.4% | 89 |
|
|
2021
Q3 | $1.14M | Sell |
10,418
-1,361
| -12% | -$149K | 0.51% | 61 |
|
|
2021
Q2 | $1.1M | Hold |
11,779
| – | – | 0.5% | 67 |
|
|
2021
Q1 | $1.08M | Sell |
11,779
-548
| -4% | -$50.4K | 0.4% | 75 |
|
|
2020
Q4 | $902K | Sell |
12,327
-4,477
| -27% | -$328K | 0.36% | 77 |
|
|
2020
Q3 | $1.31M | Sell |
16,804
-7,121
| -30% | -$553K | 0.57% | 53 |
|
|
2020
Q2 | $1.33M | Sell |
23,925
-4,489
| -16% | -$250K | 0.63% | 53 |
|
|
2020
Q1 | $842K | Buy |
28,414
+6,660
| +31% | +$197K | 0.43% | 54 |
|
|
2019
Q4 | $787K | Hold |
21,754
| – | – | 0.29% | 64 |
|
|
2019
Q3 | $592K | Sell |
21,754
-2,605
| -11% | -$70.9K | 0.19% | 66 |
|
|
2019
Q2 | $586K | Sell |
24,359
-2,393
| -9% | -$57.6K | 0.17% | 73 |
|
|
2019
Q1 | $707K | Sell |
26,752
-1,432
| -5% | -$37.8K | 0.14% | 68 |
|
|
2018
Q4 | $551K | Sell |
28,184
-3,524
| -11% | -$68.9K | 0.1% | 73 |
|
|
2018
Q3 | $621K | Buy |
+31,708
| New | +$621K | 0.08% | 76 |
|